Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy
出版年份 2022 全文链接
标题
Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy
作者
关键词
-
出版物
Acta Pharmaceutica Sinica B
Volume 12, Issue 12, Pages 4327-4347
出版商
Elsevier BV
发表日期
2022-11-04
DOI
10.1016/j.apsb.2022.11.001
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments
- (2022) Shogo Kumagai et al. CANCER CELL
- The impact of protein corona on the biological behavior of targeting nanomedicines
- (2022) Masoud Farshbaf et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Combination strategies with PD-1/PD-L1 blockade: current advances and future directions
- (2022) Ming Yi et al. Molecular Cancer
- A BRD4 PROTAC nanodrug for glioma therapy via the intervention of tumor cells proliferation, apoptosis and M2 macrophages polarization
- (2022) Tingting Yang et al. Acta Pharmaceutica Sinica B
- Metabolic Reprogramming by Dual-targeting Biomimetic Nanoparticles for Enhanced Tumor Chemo-Immunotherapy
- (2022) Shuya Zang et al. Acta Biomaterialia
- Restoration of the Immunogenicity of Tumor Cells for Enhanced Cancer Therapy via Nanoparticle‐Mediated Copper Chaperone Inhibition
- (2022) Feixiang Ding et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- ATP-exhausted nanocomplexes for intratumoral metabolic intervention and photoimmunotherapy
- (2022) Mian Yu et al. BIOMATERIALS
- Cancer Immunoediting in the Era of Immuno-oncology
- (2022) Matthew M. Gubin et al. CLINICAL CANCER RESEARCH
- When artificial intelligence meets PD-1/PD-L1 inhibitors: Population screening, response prediction and efficacy evaluation
- (2022) Weiqiu Jin et al. COMPUTERS IN BIOLOGY AND MEDICINE
- PD-L1 siRNA–hyaluronic acid conjugate for dual-targeted cancer immunotherapy
- (2022) Suyeon Kim et al. JOURNAL OF CONTROLLED RELEASE
- Tumor-associated macrophages of the M1/M2 phenotype are involved in the regulation of malignant biological behavior of breast cancer cells through the EMT pathway
- (2022) Zhuo Chen et al. MEDICAL ONCOLOGY
- Copper induces cell death by targeting lipoylated TCA cycle proteins
- (2022) Peter Tsvetkov et al. SCIENCE
- Reversing insufficient photothermal therapy-induced tumor relapse and metastasis by regulating cancer-associated fibroblasts
- (2022) Xin Li et al. Nature Communications
- Copackaging photosensitizer and PD-L1 siRNA in a nucleic acid nanogel for synergistic cancer photoimmunotherapy
- (2022) Yuanyuan Guo et al. Science Advances
- Nano-delivery of salvianolic acid B induces the quiescence of tumor-associated fibroblasts via interfering with TGF-β1/Smad signaling to facilitate chemo- and immunotherapy in desmoplastic tumor
- (2022) Yunna Chen et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Delivery of an ectonucleotidase inhibitor with ROS-responsive nanoparticles overcomes adenosine-mediated cancer immunosuppression
- (2022) Chengqiong Mao et al. Science Translational Medicine
- Toll-like receptor (TLR) agonists as a driving force behind next-generation vaccine adjuvants and cancer therapeutics
- (2022) Arshpreet Kaur et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Myeloid derived suppressor cells and innate immune system interaction in tumor microenvironment
- (2022) Anik Pramanik et al. LIFE SCIENCES
- MHC Class I Loss in Triple-negative Breast Cancer
- (2021) Anna C. Dusenbery et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Critical immunosuppressive effect of MDSC‑derived exosomes in the tumor microenvironment
- (2021) Mohammad Rashid et al. ONCOLOGY REPORTS
- The reversed intra- and extracellular pH in tumors as a unified strategy to chemotherapeutic delivery using targeted nanocarriers
- (2021) Edgar Pérez-Herrero et al. Acta Pharmaceutica Sinica B
- Nanomedicine‐Boosting Tumor Immunogenicity for Enhanced Immunotherapy
- (2021) Jing Huang et al. ADVANCED FUNCTIONAL MATERIALS
- Shape Transformable Strategies for Drug Delivery
- (2021) Wenfeng Jia et al. ADVANCED FUNCTIONAL MATERIALS
- Phototherapy and anti-GITR antibody-based therapy synergistically reinvigorate immunogenic cell death and reject established cancers
- (2021) Qi Sun et al. BIOMATERIALS
- Immunomodulating nano-adaptors potentiate antibody-based cancer immunotherapy
- (2021) Cheng-Tao Jiang et al. Nature Communications
- Immune Checkpoint Inhibitor‐Based Strategies for Synergistic Cancer Therapy
- (2021) Mengying He et al. Advanced Healthcare Materials
- Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation
- (2021) Karthik Dhatchinamoorthy et al. Frontiers in Immunology
- Effect of physicochemical properties on in vivo fate of nanoparticle-based cancer immunotherapies
- (2021) Yongchao Wang et al. Acta Pharmaceutica Sinica B
- Recent Advances in Cancer Immunotherapy
- (2021) Kenichi Suda Biomolecules
- Engineering oxygen-deficient ZrO2-x nanoplatform as therapy-activated “immunogenic cell death (ICD)” inducer to synergize photothermal-augmented sonodynamic tumor elimination in NIR-II biological window
- (2021) Xiaodan Jiao et al. BIOMATERIALS
- MDSC: Markers, development, states, and unaddressed complexity
- (2021) Samarth Hegde et al. IMMUNITY
- Enhancing Cancer Immunotherapy Treatment Goals by Using Nanoparticle Delivery System
- (2021) Tobias Achu Muluh et al. International Journal of Nanomedicine
- Tubeimoside-1 induces TFEB-dependent lysosomal degradation of PD-L1 and promotes antitumor immunity by targeting mTOR
- (2021) Xiaojia Liu et al. Acta Pharmaceutica Sinica B
- Self-propelled nanomotor reconstructs tumor microenvironment through synergistic hypoxia alleviation and glycolysis inhibition for promoted anti-metastasis
- (2021) Wenqi Yu et al. Acta Pharmaceutica Sinica B
- Influencing factors and strategies of enhancing nanoparticles into tumors in vivo
- (2021) Mingming Zhang et al. Acta Pharmaceutica Sinica B
- Self-assembled FeS-based cascade bioreactor with enhanced tumor penetration and synergistic treatments to trigger robust cancer immunotherapy
- (2021) Hao Ren et al. Acta Pharmaceutica Sinica B
- Furin-instructed aggregated gold nanoparticles for re-educating tumor associated macrophages and overcoming breast cancer chemoresistance
- (2021) Rou Xie et al. BIOMATERIALS
- Reappraisal of anticancer nanomedicine design criteria in three types of preclinical cancer models for better clinical translation
- (2021) Xin Luan et al. BIOMATERIALS
- Tumor-Associated Macrophages as Multifaceted Regulators of Breast Tumor Growth
- (2021) Maliha Tabassum Munir et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting monoamine oxidase A-regulated tumor-associated macrophage polarization for cancer immunotherapy
- (2021) Yu-Chen Wang et al. Nature Communications
- Fucoidan-functionalized activated platelet-hitchhiking micelles simultaneously track tumor cells and remodel the immunosuppressive microenvironment for efficient metastatic cancer treatment
- (2021) Rong Guo et al. Acta Pharmaceutica Sinica B
- D-MT prompts the anti-tumor effect of oxaliplatin by inhibiting IDO expression in a mouse model of colon cancer
- (2021) Yongxi Zhang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways
- (2021) Lukas Kraehenbuehl et al. Nature Reviews Clinical Oncology
- Durvalumab: A Review in Extensive-Stage SCLC
- (2021) Zaina T. Al-Salama Targeted Oncology
- Siglec Signaling in the Tumor Microenvironment
- (2021) Eline J. H. van Houtum et al. Frontiers in Immunology
- Bioresponsive immune-booster-based prodrug nanogel for cancer immunotherapy
- (2021) Xianbin Ma et al. Acta Pharmaceutica Sinica B
- Co-delivery of photosensitizer and diclofenac through sequentially responsive bilirubin nanocarriers for combating hypoxic tumors
- (2021) Yang Zhou et al. Acta Pharmaceutica Sinica B
- Remodeling “cold” tumor immune microenvironment via epigenetic-based therapy using targeted liposomes with in situ formed albumin corona
- (2021) Yang He et al. Acta Pharmaceutica Sinica B
- Ca2+-Mediated Surface Polydopamine Engineering to Program Dendritic Cell Maturation
- (2020) Yiqiong Liu et al. ACS Applied Materials & Interfaces
- Tumor microenvironment-responsive prodrug nanoplatform via co-self-assembly of photothermal agent and IDO inhibitor for enhanced tumor penetration and cancer immunotherapy
- (2020) Yijia Liu et al. BIOMATERIALS
- Rationally Designed Polymer Conjugate for Tumor-Specific Amplification of Oxidative Stress and Boosting Antitumor Immunity
- (2020) Sheng Ma et al. NANO LETTERS
- Sialoglycans and Siglecs Can Shape the Tumor Immune Microenvironment
- (2020) Stephanie van de Wall et al. TRENDS IN IMMUNOLOGY
- Impaired death receptor signaling in leukemia causes antigen-independent resistance by inducing CAR T cell dysfunction
- (2020) Nathan Singh et al. Cancer Discovery
- Checkpoint molecules coordinately restrain hyperactivated effector T cells in the tumor microenvironment
- (2020) Min Yang et al. OncoImmunology
- Photothermal Depletion of Cancer-Associated Fibroblasts Normalizes Tumor Stiffness in Desmoplastic Cholangiocarcinoma
- (2020) Alba Nicolás-Boluda et al. ACS Nano
- Reprogramming Tumor Microenvironment with Photothermal Therapy
- (2020) Qinglian Hu et al. BIOCONJUGATE CHEMISTRY
- Macrophage-mimic shape changeable nanomedicine retained in tumor for multimodal therapy of breast cancer
- (2020) Rui Liu et al. JOURNAL OF CONTROLLED RELEASE
- EMA Review of Axicabtagene Ciloleucel (Yescarta) for the Treatment of Diffuse Large B‐Cell Lymphoma
- (2020) Irene Papadouli et al. ONCOLOGIST
- The role of tumor-associated macrophages (TAMs) in tumor progression and relevant advance in targeted therapy
- (2020) Qiyao Yang et al. Acta Pharmaceutica Sinica B
- Computed tomography and photoacoustic imaging guided photodynamic therapy against breast cancer based on mesoporous platinum with in-situ oxygen generation ability
- (2020) Lingyan Zhang et al. Acta Pharmaceutica Sinica B
- Nanomedicine-based drug delivery towards tumor biological and immunological microenvironment
- (2020) Jin Li et al. Acta Pharmaceutica Sinica B
- Loss of MHC Class I Expression in HPV-associated Cervical and Vulvar Neoplasia
- (2020) Megan E. Dibbern et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
- (2020) Yuanyuan Zhang et al. Cellular & Molecular Immunology
- Combined hybrid structure of siRNA tailed IVT mRNA (ChriST mRNA) for enhancing DC maturation and subsequent anticancer T cell immunity
- (2020) Kyuri Lee et al. JOURNAL OF CONTROLLED RELEASE
- Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors
- (2020) Lorenzo Galluzzi et al. Nature Reviews Clinical Oncology
- Stimuli-responsive prodrug-based cancer nanomedicine
- (2020) Angel Xie et al. EBioMedicine
- The progress and perspective of nanoparticle-enabled tumor metastasis treatment
- (2020) Wei Zhang et al. Acta Pharmaceutica Sinica B
- Dual-targeting nanovesicles enhance specificity to dynamic tumor cells in vitro and in vivo via manipulation of αvβ3-ligand binding
- (2020) Yang Song et al. Acta Pharmaceutica Sinica B
- Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors
- (2020) Qingyang Lei et al. Frontiers in Cell and Developmental Biology
- What Went Wrong with Anticancer Nanomedicine Design and How to Make It Right
- (2020) Duxin Sun et al. ACS Nano
- Phagocyte-membrane-coated and laser-responsive nanoparticles control primary and metastatic cancer by inducing anti-tumor immunity
- (2020) Chuan Hu et al. BIOMATERIALS
- IDO-inhibitor potentiated immunogenic chemotherapy abolishes primary tumor growth and eradicates metastatic lesions by targeting distinct compartments within tumor microenvironment
- (2020) Qilin Li et al. BIOMATERIALS
- Developing neobavaisoflavone nanoemulsion suppresses lung cancer progression by regulating tumor microenvironment
- (2020) Hui Ye et al. BIOMEDICINE & PHARMACOTHERAPY
- Erythrocyte-derived drug delivery systems in cancer therapy
- (2020) Yishen Mao et al. CHINESE CHEMICAL LETTERS
- Unconventional Peptide Presentation by Classical MHC Class I and Implications for T and NK Cell Activation
- (2020) Dirk M. Zajonc INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MHC class I loss in endometrial carcinoma: a potential resistance mechanism to immune checkpoint inhibition
- (2020) Lisa A. Friedman et al. MODERN PATHOLOGY
- Targeting STAT3 in Cancer Immunotherapy
- (2020) Sailan Zou et al. Molecular Cancer
- Anti-angiogenic Agents in Combination With Immune Checkpoint Inhibitors: A Promising Strategy for Cancer Treatment
- (2020) Yuxiao Song et al. Frontiers in Immunology
- A tumor-to-lymph procedure navigated versatile gel system for combinatorial therapy against tumor recurrence and metastasis
- (2020) Lin Qin et al. Science Advances
- GSH-responsive SN38 dimer-loaded shape-transformable nanoparticles with iRGD for enhancing chemo-photodynamic therapy
- (2020) Congcong Lin et al. Acta Pharmaceutica Sinica B
- Photothermal/matrix metalloproteinase-2 dual-responsive gelatin nanoparticles for breast cancer treatment
- (2020) Xiaojie Chen et al. Acta Pharmaceutica Sinica B
- Nanomedicines modulating tumor immunosuppressive cells to enhance cancer immunotherapy
- (2020) Yuefei Zhu et al. Acta Pharmaceutica Sinica B
- Manipulation of immune‒vascular crosstalk: new strategies towards cancer treatment
- (2020) Yang Zhao et al. Acta Pharmaceutica Sinica B
- Cancer Metabolism: Phenotype, Signaling and Therapeutic Targets
- (2020) Jae Hyung Park et al. Cells
- New emerging targets in cancer immunotherapy: the role of GITR
- (2020) Giulia Buzzatti et al. ESMO Open
- Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance
- (2020) Sreya Bagchi et al. Annual Review of Pathology-Mechanisms of Disease
- Discovery of VEGFR-2 inhibitors exerting significant anticancer activity against CD44+ and CD133+ cancer stem cells (CSCs): Reversal of TGF-β induced epithelial-mesenchymal transition (EMT) in hepatocellular carcinoma
- (2020) Siddharth J. Modi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Tumor-associated macrophage, angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients
- (2020) Ilseon Hwang et al. Journal of Translational Medicine
- Targeting immunogenic cell death in cancer
- (2020) Asma Ahmed et al. Molecular Oncology
- Immune checkpoints in targeted-immunotherapy of pancreatic cancer: New hope for clinical development
- (2020) Seyed Hossein Kiaie et al. Acta Pharmaceutica Sinica B
- The progress and perspective of strategies to improve tumor penetration of nanomedicines
- (2020) Jiang Hu et al. CHINESE CHEMICAL LETTERS
- CAR-T cells: Early successes in blood cancer and challenges in solid tumors
- (2020) Hassan Dana et al. Acta Pharmaceutica Sinica B
- Delivery technologies for cancer immunotherapy
- (2019) Rachel S. Riley et al. NATURE REVIEWS DRUG DISCOVERY
- Carbon-dot-supported atomically dispersed gold as a mitochondrial oxidative stress amplifier for cancer treatment
- (2019) Ningqiang Gong et al. Nature Nanotechnology
- Discovery of potent indoleamine 2,3-dioxygenase (IDO) inhibitor from alkaloids in Picrasma quassioides by virtual screening and in vitro evaluation
- (2019) Ning Wang et al. FITOTERAPIA
- VEGF in Signaling and Disease: Beyond Discovery and Development
- (2019) Rajendra S. Apte et al. CELL
- Hypoxia alleviation-triggered enhanced photodynamic therapy in combination with IDO inhibitor for preferable cancer therapy
- (2019) Lei Xing et al. BIOMATERIALS
- The role of PD-1/PD-L1 axis and macrophage in the progression and treatment of cancer
- (2019) Jiajing Cai et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Tumor Microenvironment‐Responsive Dual Drug Dimer‐Loaded PEGylated Bilirubin Nanoparticles for Improved Drug Delivery and Enhanced Immune‐Chemotherapy of Breast Cancer
- (2019) Xiaotong Yang et al. ADVANCED FUNCTIONAL MATERIALS
- Understanding and overcoming the resistance of cancer to PD-1/PD-L1 blockade
- (2019) Amy L. Shergold et al. PHARMACOLOGICAL RESEARCH
- Cdk5 knocking out mediated by CRISPR-Cas9 genome editing for PD-L1 attenuation and enhanced antitumor immunity
- (2019) Huan Deng et al. Acta Pharmaceutica Sinica B
- Reshaping Prostate Tumor Microenvironment To Suppress Metastasis via Cancer-Associated Fibroblast Inactivation with Peptide-Assembly-Based Nanosystem
- (2019) Jiayan Lang et al. ACS Nano
- The sialoglycan-Siglec glyco-immune checkpoint – a target for improving innate and adaptive anti-cancer immunity
- (2019) Anne Bärenwaldt et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- The Dark Side of Fibroblasts: Cancer-Associated Fibroblasts as Mediators of Immunosuppression in the Tumor Microenvironment
- (2019) Lea Monteran et al. Frontiers in Immunology
- Sequentially responsive biomimetic nanoparticles with optimal size in combination with checkpoint blockade for cascade synergetic treatment of breast cancer and lung metastasis
- (2019) Wenqi Yu et al. BIOMATERIALS
- Anti-VEGF/VEGFR2 monoclonal antibodies and their combinations with PD-1/PD-L1 inhibitors in clinic
- (2019) Feng Gao et al. CURRENT CANCER DRUG TARGETS
- Aggregable Nanoparticles-Enabled Chemotherapy and Autophagy Inhibition Combined with Anti-PD-L1 Antibody for Improved Glioma Treatment
- (2019) Shaobo Ruan et al. NANO LETTERS
- The European Medicines Agency Review of Kymriah (Tisagenlecleucel) for the Treatment of Acute Lymphoblastic Leukemia and Diffuse Large B‐Cell Lymphoma
- (2019) Sahra Ali et al. ONCOLOGIST
- Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth
- (2019) Meng Cao et al. Journal for ImmunoTherapy of Cancer
- Breast Cancer Cells and PD-1/PD-L1 Blockade Upregulate the Expression of PD-1, CTLA-4, TIM-3 and LAG-3 Immune Checkpoints in CD4+ T Cells
- (2019) Saleh et al. Vaccines
- Crucial players in glycolysis: Cancer progress
- (2019) Zaka Abbaszadeh et al. GENE
- Self-Delivery Micellar Nanoparticles Prevent Premetastatic Niche Formation by Interfering with the Early Recruitment and Vascular Destruction of Granulocytic Myeloid-Derived Suppressor Cells
- (2019) Yang Long et al. NANO LETTERS
- Preserving the CTLA-4 Checkpoint for Safer and More Effective Cancer Immunotherapy
- (2019) Yang Liu et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- A hispanolone-derived diterpenoid inhibits M2-Macrophage polarization in vitro via JAK/STAT and attenuates chitin induced inflammation in vivo
- (2018) Lidia Jiménez-García et al. BIOCHEMICAL PHARMACOLOGY
- Immuno-modulators enhance antigen-specific immunity and anti-tumor effects of mesothelin-specific chimeric DNA vaccine through promoting DC maturation
- (2018) Yu-Li Chen et al. CANCER LETTERS
- Evolving Roles for Targeting CTLA-4 in Cancer Immunotherapy
- (2018) Yinghao Zhao et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- The transition from HLA-I positive to HLA-I negative primary tumors: the road to escape from T-cell responses
- (2018) Natalia Aptsiauri et al. CURRENT OPINION IN IMMUNOLOGY
- Targeting the tumour stroma to improve cancer therapy
- (2018) Kenneth C. Valkenburg et al. Nature Reviews Clinical Oncology
- Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
- (2018) Dai Fukumura et al. Nature Reviews Clinical Oncology
- Combination antitumor immunotherapy with VEGF and PIGF siRNA via systemic delivery of multi-functionalized nanoparticles to tumor-associated macrophages and breast cancer cells
- (2018) Yudong Song et al. BIOMATERIALS
- Paclitaxel reduces tumor growth by reprogramming tumor-associated macrophages to an M1- profile in a TLR4-dependent manner
- (2018) Carlos W Wanderley et al. CANCER RESEARCH
- Nanoparticle-Mediated Remodeling of the Tumor Microenvironment to Enhance Immunotherapy
- (2018) Sara Musetti et al. ACS Nano
- The impact of protein corona on the behavior and targeting capability of nanoparticle-based delivery system
- (2018) Wei Xiao et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- HIP1R targets PD-L1 to lysosomal degradation to alter T cell–mediated cytotoxicity
- (2018) Huanbin Wang et al. Nature Chemical Biology
- Turning foes to friends: targeting cancer-associated fibroblasts
- (2018) Xueman Chen et al. NATURE REVIEWS DRUG DISCOVERY
- Repolarization of myeloid derived suppressor cells via magnetic nanoparticles to promote radiotherapy for glioma treatment
- (2018) Congyu Wu et al. Nanomedicine-Nanotechnology Biology and Medicine
- Co-delivery of RNAi and chemokine by polyarginine nanocapsules enables the modulation of myeloid-derived suppressor cells
- (2018) Adriana M. Ledo et al. JOURNAL OF CONTROLLED RELEASE
- Nanomedicine Strategies to Target Tumor-Associated Macrophages
- (2017) Karin Binnemars-Postma et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Protein corona: a new approach for nanomedicine design
- (2017) Van Hong Nguyen et al. International Journal of Nanomedicine
- Spatio-temporal control strategy of drug delivery systems based nano structures
- (2017) Nahla Rahoui et al. JOURNAL OF CONTROLLED RELEASE
- PD-1 checkpoint inhibition: Toxicities and management
- (2017) Andrew W. Hahn et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- BIX02189 inhibits TGF-β1-induced lung cancer cell metastasis by directly targeting TGF-β type I receptor
- (2016) Seong Ji Park et al. CANCER LETTERS
- The Emerging Hallmarks of Cancer Metabolism
- (2016) Natalya N. Pavlova et al. Cell Metabolism
- Regulatory T cells in cancer immunotherapy
- (2016) Atsushi Tanaka et al. CELL RESEARCH
- Calreticulin acts as an adjuvant to promote dendritic cell maturation and enhances antigen-specific cytotoxic T lymphocyte responses against non-small cell lung cancer cells
- (2016) Xinli Liu et al. CELLULAR IMMUNOLOGY
- TGF-β Signaling in Cancer
- (2016) Viqar Syed JOURNAL OF CELLULAR BIOCHEMISTRY
- To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?
- (2016) F. Danhier JOURNAL OF CONTROLLED RELEASE
- IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance
- (2016) David H. Munn et al. TRENDS IN IMMUNOLOGY
- Differential expression of major histocompatibility complex class I in subtypes of breast cancer is associated with estrogen receptor and interferon signaling
- (2016) Hee Jin Lee et al. Oncotarget
- Blocking of the PD-1/PD-L1 Interaction by aD-Peptide Antagonist for Cancer Immunotherapy
- (2015) Hao-Nan Chang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies
- (2015) J. Naidoo et al. ANNALS OF ONCOLOGY
- Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
- (2015) Edgar Pérez-Herrero et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- From mice to humans: developments in cancer immunoediting
- (2015) Michele W.L. Teng et al. JOURNAL OF CLINICAL INVESTIGATION
- The Multifaceted Role of Curcumin in Cancer Prevention and Treatment
- (2015) Muthu Shanmugam et al. MOLECULES
- Targeting CCR4 as an emerging strategy for cancer therapy and vaccines
- (2014) Jagadeesh Bayry et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Tumor-Associated Macrophages as Major Players in the Tumor Microenvironment
- (2014) Theerawut Chanmee et al. Cancers
- Altered Tumor-Cell Glycosylation Promotes Metastasis
- (2014) Irina Häuselmann et al. Frontiers in Oncology
- Nanomedicine therapeutic approaches to overcome cancer drug resistance
- (2013) Janet L. Markman et al. ADVANCED DRUG DELIVERY REVIEWS
- Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy
- (2013) Matthew D. Vesely et al. Annals of the New York Academy of Sciences
- Cytokine patterns in patients with cancer: a systematic review
- (2013) Bodo E Lippitz LANCET ONCOLOGY
- New Aspects of an Old Drug – Diclofenac Targets MYC and Glucose Metabolism in Tumor Cells
- (2013) Eva Gottfried et al. PLoS One
- The stimulatory effect of TLRs ligands on maturation of chicken bone marrow-derived dendritic cells
- (2013) Jinfeng Liang et al. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
- VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2
- (2012) N G Gavalas et al. BRITISH JOURNAL OF CANCER
- Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2
- (2012) Tadashi Yokosuka et al. JOURNAL OF EXPERIMENTAL MEDICINE
- What are regulatory T cells (Treg) regulating in cancer and why?
- (2012) Theresa L. Whiteside SEMINARS IN CANCER BIOLOGY
- Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape
- (2011) S.-R. Woo et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- From Tumor Immunosuppression to Eradication: Targeting Homing and Activity of Immune Effector Cells to Tumors
- (2011) Oana Draghiciu et al. Clinical & Developmental Immunology
- Tumor Immune Escape Mechanisms that Operate During Metastasis
- (2011) D. O. Croci et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Cell-mediated drug delivery
- (2011) Elena V Batrakova et al. Expert Opinion on Drug Delivery
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Drug delivery and nanoparticles: Applications and hazards
- (2010) de Jong International Journal of Nanomedicine
- Glycan changes: cancer metastasis and anti-cancer vaccines
- (2010) Min Li et al. JOURNAL OF BIOSCIENCES
- TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progression
- (2010) Li Yang et al. TRENDS IN IMMUNOLOGY
- TGF-β-induced epithelial to mesenchymal transition
- (2009) Jian Xu et al. CELL RESEARCH
- VEGF induces expression of Bcl-2 and multiple signaling factors in microvascular endothelial cells in a prostate cancer model
- (2009) Yoshihisa Sakai et al. WORLD JOURNAL OF UROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now